Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma.
Gallo-Oller G, Pons G, Sansa-Girona J, Navarro N, Zarzosa P, García-Gilabert L, Cabré-Fernandez P, Guillén Burrieza G, Valero-Arrese L, Segura MF, Lizcano JM, Sánchez de Toledo J, Moreno L, Gallego S, Roma J. Gallo-Oller G, et al. Among authors: segura mf. Exp Hematol Oncol. 2024 Apr 5;13(1):38. doi: 10.1186/s40164-024-00503-9. Exp Hematol Oncol. 2024. PMID: 38581035 Free PMC article.
Advances in the approaches used to repurpose drugs for neuroblastoma.
Miera-Maluenda M, Pérez-Torres M, Mañas A, Rubio-San-Simón A, Butjosa-Espín M, Ruiz-Duran P, Seoane JA, Moreno L, Segura MF. Miera-Maluenda M, et al. Among authors: segura mf. Expert Opin Drug Discov. 2024 Sep 11:1-11. doi: 10.1080/17460441.2024.2402413. Online ahead of print. Expert Opin Drug Discov. 2024. PMID: 39258785 Review.
In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma.
Murphy C, Devis-Jauregui L, Struck R, Boloix A, Gallagher C, Gavin C, Cottone F, Fernandez AS, Madden S, Roma J, Segura MF, Piskareva O. Murphy C, et al. Among authors: segura mf. PLoS One. 2024 May 29;19(5):e0303643. doi: 10.1371/journal.pone.0303643. eCollection 2024. PLoS One. 2024. PMID: 38809883 Free PMC article.
Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis.
Malhotra S, Fissolo N, Rodríguez-Rivera C, Monreal E, Montpeyo M, Urcelay E, Triviño JC, Pérez-García MJ, Segura MF, Pappolla A, Río J, Vilaseca A, Fernández Velasco JI, Miguez A, Goicoechea C, Martinez-Vicente M, Villar LM, Montalban X, Comabella M. Malhotra S, et al. Among authors: segura mf. Clin Transl Med. 2024 Apr;14(4):e1654. doi: 10.1002/ctm2.1654. Clin Transl Med. 2024. PMID: 38591764 Free PMC article. No abstract available.
Targeting the Hedgehog Pathway in Rhabdomyosarcoma.
Zarzosa P, Garcia-Gilabert L, Hladun R, Guillén G, Gallo-Oller G, Pons G, Sansa-Girona J, Segura MF, Sánchez de Toledo J, Moreno L, Gallego S, Roma J. Zarzosa P, et al. Among authors: segura mf. Cancers (Basel). 2023 Jan 24;15(3):727. doi: 10.3390/cancers15030727. Cancers (Basel). 2023. PMID: 36765685 Free PMC article. Review.
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma.
Navarro N, Molist C, Sansa-Girona J, Zarzosa P, Gallo-Oller G, Pons G, Magdaleno A, Guillén G, Hladun R, Garrido M, Segura MF, Hontecillas-Prieto L, de Álava E, Ponsati B, Fernández-Carneado J, Almazán-Moga A, Vallès-Miret M, Farrera-Sinfreu J, de Toledo JS, Moreno L, Gallego S, Roma J. Navarro N, et al. Among authors: segura mf. Cell Mol Life Sci. 2022 Oct 11;79(11):546. doi: 10.1007/s00018-022-04557-y. Cell Mol Life Sci. 2022. PMID: 36221013 Free PMC article.
80 results